Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Metabolic perturbance in autism spectrum disorders: a metabolomics study.

Ming X, Stein TP, Barnes V, Rhodes N, Guo L.

J Proteome Res. 2012 Dec 7;11(12):5856-62. doi: 10.1021/pr300910n. Epub 2012 Nov 9.

PMID:
23106572
2.

Metabolomics characterization of energy metabolism reveals glycogen accumulation in gut-microbiota-lacking mice.

Chuang HL, Huang YT, Chiu CC, Liao CD, Hsu FL, Huang CC, Hou CC.

J Nutr Biochem. 2012 Jul;23(7):752-8. doi: 10.1016/j.jnutbio.2011.03.019. Epub 2011 Aug 12.

PMID:
21840188
3.

1H-13C NMR-based urine metabolic profiling in autism spectrum disorders.

Mavel S, Nadal-Desbarats L, Blasco H, Bonnet-Brilhault F, Barthélémy C, Montigny F, Sarda P, Laumonnier F, Vourc'h P, Andres CR, Emond P.

Talanta. 2013 Sep 30;114:95-102. doi: 10.1016/j.talanta.2013.03.064. Epub 2013 Apr 9.

4.

Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.

Gevi F, Zolla L, Gabriele S, Persico AM.

Mol Autism. 2016 Nov 24;7:47. eCollection 2016.

5.

The footprints of gut microbial-mammalian co-metabolism.

Zheng X, Xie G, Zhao A, Zhao L, Yao C, Chiu NH, Zhou Z, Bao Y, Jia W, Nicholson JK, Jia W.

J Proteome Res. 2011 Dec 2;10(12):5512-22. doi: 10.1021/pr2007945. Epub 2011 Oct 24.

PMID:
21970572
6.

Gut permeability in autism spectrum disorders.

Dalton N, Chandler S, Turner C, Charman T, Pickles A, Loucas T, Simonoff E, Sullivan P, Baird G.

Autism Res. 2014 Jun;7(3):305-13. doi: 10.1002/aur.1350. Epub 2013 Dec 12.

PMID:
24339339
7.

Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?

Wang L, Angley MT, Gerber JP, Young RL, Abarno DV, McKinnon RA, Sorich MJ.

Biomarkers. 2009 Dec;14(8):596-603. doi: 10.3109/13547500903183962.

PMID:
19697973
8.

The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings.

Noto A, Fanos V, Barberini L, Grapov D, Fattuoni C, Zaffanello M, Casanova A, Fenu G, De Giacomo A, De Angelis M, Moretti C, Papoff P, Ditonno R, Francavilla R.

J Matern Fetal Neonatal Med. 2014 Oct;27 Suppl 2:46-52. doi: 10.3109/14767058.2014.954784.

PMID:
25284177
9.

Combined 1H-NMR and 1H-13C HSQC-NMR to improve urinary screening in autism spectrum disorders.

Nadal-Desbarats L, Aïdoud N, Emond P, Blasco H, Filipiak I, Sarda P, Bonnet-Brilhault F, Mavel S, Andres CR.

Analyst. 2014 Jul 7;139(13):3460-8. doi: 10.1039/c4an00552j.

PMID:
24841505
10.

Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.

Mussap M, Noto A, Fanos V.

Expert Rev Mol Diagn. 2016 Aug;16(8):869-81. doi: 10.1080/14737159.2016.1202765. Epub 2016 Jun 30. Review.

PMID:
27310602
11.

Metabolomics Study of Urine in Autism Spectrum Disorders Using a Multiplatform Analytical Methodology.

Diémé B, Mavel S, Blasco H, Tripi G, Bonnet-Brilhault F, Malvy J, Bocca C, Andres CR, Nadal-Desbarats L, Emond P.

J Proteome Res. 2015 Dec 4;14(12):5273-82. doi: 10.1021/acs.jproteome.5b00699. Epub 2015 Nov 23.

PMID:
26538324
12.

Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls.

Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK.

J Proteome Res. 2010 Jun 4;9(6):2996-3004. doi: 10.1021/pr901188e.

13.

Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study.

Kuwabara H, Yamasue H, Koike S, Inoue H, Kawakubo Y, Kuroda M, Takano Y, Iwashiro N, Natsubori T, Aoki Y, Kano Y, Kasai K.

PLoS One. 2013 Sep 18;8(9):e73814. doi: 10.1371/journal.pone.0073814. eCollection 2013.

14.

Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome?

Wang L, Angley MT, Sorich MJ, Young RL, McKinnon RA, Gerber JP.

Autism Res. 2010 Oct;3(5):268-72. doi: 10.1002/aur.145.

PMID:
20589913
15.

Identification of metabolic pathway disturbances using multimodal metabolomics in autistic disorders in a Middle Eastern population.

Bitar T, Mavel S, Emond P, Nadal-Desbarats L, Lefèvre A, Mattar H, Soufia M, Blasco H, Vourc'h P, Hleihel W, Andres CR.

J Pharm Biomed Anal. 2018 Apr 15;152:57-65. doi: 10.1016/j.jpba.2018.01.007. Epub 2018 Feb 3.

PMID:
29414019
16.

GC-MS-based urine metabolic profiling of autism spectrum disorders.

Emond P, Mavel S, Aïdoud N, Nadal-Desbarats L, Montigny F, Bonnet-Brilhault F, Barthélémy C, Merten M, Sarda P, Laumonnier F, Vourc'h P, Blasco H, Andres CR.

Anal Bioanal Chem. 2013 Jun;405(15):5291-300. doi: 10.1007/s00216-013-6934-x. Epub 2013 Apr 10.

17.

Gut microbial activity, implications for health and disease: the potential role of metabolite analysis.

Nyangale EP, Mottram DS, Gibson GR.

J Proteome Res. 2012 Dec 7;11(12):5573-85. doi: 10.1021/pr300637d. Epub 2012 Nov 1. Review.

PMID:
23116228
18.

Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders.

Han Y, Xi QQ, Dai W, Yang SH, Gao L, Su YY, Zhang X.

Int J Dev Neurosci. 2015 Nov;46:27-32. doi: 10.1016/j.ijdevneu.2015.06.006. Epub 2015 Jul 3.

PMID:
26150135
19.

The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members.

Wang LW, Tancredi DJ, Thomas DW.

J Dev Behav Pediatr. 2011 Jun;32(5):351-60. doi: 10.1097/DBP.0b013e31821bd06a.

PMID:
21555957
20.

Evaluating effects of penicillin treatment on the metabolome of rats.

Sun J, Schnackenberg LK, Khare S, Yang X, Greenhaw J, Salminen W, Mendrick DL, Beger RD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Aug 1;932:134-43. doi: 10.1016/j.jchromb.2013.05.030. Epub 2013 Jun 7.

PMID:
23831706

Supplemental Content

Support Center